AbbVie | ABBV - EPS Earnings Per Share


AbbVie reported $3.82 in EPS Earnings Per Share for its fiscal quarter ending in September of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q3 Sep/2026 3.82 3.84 1.86 Oct/30
FY2026Q2 Jun/2026 3.65 3.76 2.97 Jul/31
FY2026Q1 Mar/2026 2.65 3.01 2.46 Apr/29
FY2025Q4 Dec/2025 2.71 3.35 2.16 Feb/04
FY2025Q3 Sep/2025 1.86 3.26 3.00 Oct/31




Eps Change Date
AbbVie USD 3.82 0.17 Sep/2026
Abbott USD 0.53 0.78 Sep/2026
ALKERMES USD 0 0.4 Jun/2026
Amgen USD 6.29 1.14 Jun/2026
AstraZeneca USD 2.79 0.16 Sep/2026
Biogen USD 2.62 0.98 Sep/2026
BioMarin Pharmaceutical USD 1.2 0.44 Jun/2026
Bristol-Myers Squibb USD 1.35 0.69 Sep/2026
Coherus Biosciences USD -0.43 0.06 Dec/2025
Eisai JPY 64.71 76.24 Jun/2026
Eli Lilly USD 7.48 0.9 Sep/2026
Gilead Sciences USD 2.55 9.3 Sep/2026
GlaxoSmithKline GBP 0.55 0.04 Sep/2026
J&J USD 2.7 0.2 Sep/2026
Medtronic USD 1.45 0.1 Jun/2026
Merck USD 2.49 2.62 Sep/2026
Neurocrine Biosciences USD 2.85 0.91 Jun/2026
Novartis USD 2.46 0.05 Sep/2026
Pacira USD 0.73 0.13 Jun/2026
Perrigo USD 0.5 0.07 Jun/2026
Pfizer USD 0.77 0.02 Jun/2026
Regeneron Pharmaceuticals USD 20.07 5.78 Sep/2026
Roche Holding CHF 10.98 2.61 Jun/2026
Sanofi EUR 3.55 1.46 Sep/2026
UCB EUR 5.65 3.21 Dec/2025
Ultragenyx Pharmaceutical USD -0.9 0.94 Jun/2026
United Therapeutics USD 7.27 1.45 Jun/2026
Vertex Pharmaceuticals USD 4.73 0.26 Jun/2026
Zoetis USD 1.87 0.34 Jun/2026